Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway

Biochemical and Biophysical Research Communications

Volumn 366, Issue 4, 2008, Pages 1061-1066

  Raheja, Leah Forquer ^a   Genetos, Damian C ^b   Yellowley, Clare E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

CD44; Cell migration; Chemotaxis; Fracture; Hypoxia; Mesenchymal stem cell; MSC; Osteopontin

Indexed keywords

HERMES ANTIGEN; NEUTRALIZING ANTIBODY; OSTEOPONTIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONCENTRATION RESPONSE; FRACTURE; FRACTURE HEALING; HUMAN; HUMAN CELL; HYPOXIA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTIGENS, CD44; CELL HYPOXIA; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MESENCHYMAL STEM CELLS; NEUTRALIZATION TESTS; OSTEOCYTES; OSTEOPONTIN; RECOMBINANT PROTEINS;

EID: 37549017616     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.076     Document Type: Article

References (39)

1. Bruder S.P., Fink D.J., and Caplan A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell. Biochem. 56 (1994) 283-294
2. Gerstenfeld L.C. Fracture healing: the biology of bone repair and regeneration. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (2006), American Society of Bone and Mineral Research, Washington DC 42-48
3. Somerman M., Hewitt A.T., Varner H.H., Schiffmann E., Termine J., and Reddi A.H. Identification of a bone matrix-derived chemotactic factor. Calcif. Tissue Int. 35 (1983) 481-485
4. Lucas P.A., Syftestad G.T., and Caplan A.I. Partial isolation and characterization of a chemotactic factor from adult bovine bone for mesenchymal cells. Bone 7 (1986) 365-371
5. Brighton C.T., and Krebs A.G. Oxygen tension of healing fractures in the rabbit. J. Bone Joint Surg. Am. 54 (1972) 323-332
6. Heppenstall R.B., Grislis G., and Hunt T.K. Tissue gas tensions and oxygen consumption in healing bone defects. Clin. Orthop. Relat. Res. (1975) 357-365
7. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., and Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem. 88 (2003) 873-884
8. Dimitriou R., Tsiridis E., and Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 36 (2005) 1392-1404
9. Brighton C.T., and Krebs A.G. Oxygen tension of nonunion of fractured femurs in the rabbit. Surg. Gynecol. Obstet. 135 (1972) 379-385
10. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88 (2000) 1474-1480
11. Kim H.H., Lee S.E., Chung W.J., Choi Y., Kwack K., Kim S.W., Kim M.S., Park H., and Lee Z.H. Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Cytokine 17 (2002) 14-27
12. Annabi B., Lee Y.T., Turcotte S., Naud E., Desrosiers R.R., Champagne M., Eliopoulos N., Galipeau J., and Beliveau R. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21 (2003) 337-347
13. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., and Khoury S.J. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA 101 (2004) 18117-18122
14. Merry K., Dodds R., Littlewood A., and Gowen M. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J. Cell Sci. 104 Pt 4 (1993) 1013-1020
15. Weber G.F., Ashkar S., Glimcher M.J., and Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271 (1996) 509-512
16. Zhu B., Suzuki K., Goldberg H.A., Rittling S.R., Denhardt D.T., McCulloch C.A., and Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J. Cell. Physiol. 198 (2004) 155-167
17. Standal T., Borset M., and Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp. Oncol. 26 (2004) 179-184
18. Sodhi C.P., Phadke S.A., Batlle D., and Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50 (2001) 1482-1490
19. Le Q.T., Sutphin P.D., Raychaudhuri S., Yu S.C., Terris D.J., Lin H.S., Lum B., Pinto H.A., Koong A.C., and Giaccia A.J. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin. Cancer Res. 9 (2003) 59-67
20. Gross T.S., King K.A., Rabaia N.A., Pathare P., and Srinivasan S. Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen. J. Bone Miner. Res. 20 (2005) 250-256
21. Genetos D.C., Geist D.J., Liu D., Donahue H.J., and Duncan R.L. Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts. J. Bone Miner. Res. 20 (2005) 41-49
22. In: Guan J. (Ed). Cell Migration: Developmental Methods and Protocols (2005), Humana Press, Totowa, New Jersey
23. Khan S.A., Cook A.C., Kappil M., Gunthert U., Chambers A.F., Tuck A.B., and Denhardt D.T. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin. Exp. Metastasis 22 (2005) 663-673
24. Zhong H., and Simons J.W. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 259 (1999) 523-526
25. Samanna V., Wei H., Ego-Osuala D., and Chellaiah M.A. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells. Exp. Cell Res. 312 (2006) 2214-2230
26. Bruder S.P., Kurth A.A., Shea M., Hayes W.C., Jaiswal N., and Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Orthop. Res. 16 (1998) 155-162
27. Shirley D., Marsh D., Jordan G., McQuaid S., and Li G. Systemic recruitment of osteoblastic cells in fracture healing. J. Orthop. Res. 23 (2005) 1013-1021
28. Steinbrech D.S., Mehrara B.J., Saadeh P.B., Chin G., Dudziak M.E., Gerrets R.P., Gittes G.K., and Longaker M.T. Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast. Reconstr. Surg. 104 (1999) 738-747
29. Steinbrech D.S., Mehrara B.J., Saadeh P.B., Greenwald J.A., Spector J.A., Gittes G.K., and Longaker M.T. Hypoxia increases insulin-like growth factor gene expression in rat osteoblasts. Ann. Plast. Surg. 44 (2000) 529-534 (discussion 534-525)
30. Tsuji M., Ikeda H., Ishizu A., Miyatake Y., Hayase H., and Yoshiki T. Altered expression of apoptosis-related genes in osteocytes exposed to high-dose steroid hormones and hypoxic stress. Pathobiology 73 (2006) 304-309
31. Liaw L., Birk D.E., Ballas C.B., Whitsitt J.S., Davidson J.M., and Hogan B.L. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101 (1998) 1468-1478
32. Tatsumi S., Ishii K., Amizuka N., Li M., Kobayashi T., Kohno K., Ito M., Takeshita S., and Ikeda K. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5 (2007) 464-475
33. Trueblood N.A., Xie Z., Communal C., Sam F., Ngoy S., Liaw L., Jenkins A.W., Wang J., Sawyer D.B., Bing O.H., Apstein C.S., Colucci W.S., and Singh K. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ. Res. 88 (2001) 1080-1087
34. Duvall C.L., Taylor W.R., Weiss D., Wojtowicz A.M., and Guldberg R.E. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J. Bone Miner. Res. 22 (2007) 286-297
35. Yamazaki M., Nakajima F., Ogasawara A., Moriya H., Majeska R.J., and Einhorn T.A. Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J. Bone Joint Surg. Br. 81 (1999) 508-515
36. Bonewald L.F. Osteocytes as dynamic, multifunctional cells. Ann. NY Acad. Sci. (2007)
37. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., and Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005) 4120-4126
38. Djouad F., Charbonnier L.M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., Cantos C., Jorgensen C., and Noel D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25 (2007) 2025-2032
39. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822